Industry Research Reports

Home > Reports > Machinery & Equipment > Global Everolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Everolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Machinery & Equipment

Published Date: 2025-02-25

Pages: 73 Pages

Report ld: 4249248

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Everolimus Market Size(US$)

CAGR 2025-2031

-7.6%

Market Size,2031

USD 221

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 356 million

Market Forecast in 2031(Value)

US$ 221 million

CAGR

-7.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Everolimus market size was US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.

Afinitor (everolimus) is a brand-name prescription medication. It"s used to treat certain types of cancers, tumors, and seizures.

Everolimus, a targeted therapy used in the treatment of various cancers, is witnessing increasing demand. Factors contributing to market growth include the rising prevalence of cancer, advancements in precision medicine, and the expanding pipeline of Afinitor for new indications. Key players in the market are investing in research and development to expand the application of Afinitor and develop combination therapies. Additionally, strategic collaborations and partnerships are driving market expansion. However, challenges such as high treatment costs and the availability of alternative therapies may hinder market growth.

The global Everolimus market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Everolimus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Novartis

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

2.5mg
5mg
7mg
10mg

Segment by Application

Hospital
Drugs Store
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Everolimus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Everolimus manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Everolimus revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Everolimus Product Scope

1.2 Everolimus by Type

1.2.1 Global Everolimus Sales by Type (2020 & 2024 & 2031)

1.2.2 2.5mg

1.2.3 5mg

1.2.4 7mg

1.2.5 10mg

1.3 Everolimus by Application

1.3.1 Global Everolimus Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospital

1.3.3 Drugs Store

1.3.4 Other

1.4 Global Everolimus Market Estimates and Forecasts (2020-2031)

1.4.1 Global Everolimus Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Everolimus Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Everolimus Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Everolimus Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Everolimus Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Everolimus Sales Market Share by Region (2020-2025)

2.2.2 Global Everolimus Revenue Market Share by Region (2020-2025)

2.3 Global Everolimus Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Everolimus Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Everolimus Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Everolimus Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Everolimus Historic Market Review by Type (2020-2025)

3.1.1 Global Everolimus Sales by Type (2020-2025)

3.1.2 Global Everolimus Revenue by Type (2020-2025)

3.1.3 Global Everolimus Price by Type (2020-2025)

3.2 Global Everolimus Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Everolimus Sales Forecast by Type (2026-2031)

3.2.2 Global Everolimus Revenue Forecast by Type (2026-2031)

3.2.3 Global Everolimus Price Forecast by Type (2026-2031)

3.3 Different Types Everolimus Representative Players

4 Global Market Size by Application

4.1 Global Everolimus Historic Market Review by Application (2020-2025)

4.1.1 Global Everolimus Sales by Application (2020-2025)

4.1.2 Global Everolimus Revenue by Application (2020-2025)

4.1.3 Global Everolimus Price by Application (2020-2025)

4.2 Global Everolimus Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Everolimus Sales Forecast by Application (2026-2031)

4.2.2 Global Everolimus Revenue Forecast by Application (2026-2031)

4.2.3 Global Everolimus Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Everolimus Application

5 Competition Landscape by Players

5.1 Global Everolimus Sales by Players (2020-2025)

5.2 Global Top Everolimus Players by Revenue (2020-2025)

5.3 Global Everolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Everolimus as of 2024)

5.4 Global Everolimus Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Everolimus, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Everolimus, Product Type & Application

5.7 Global Key Manufacturers of Everolimus, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Everolimus Sales by Company

6.1.1.1 North America Everolimus Sales by Company (2020-2025)

6.1.1.2 North America Everolimus Revenue by Company (2020-2025)

6.1.2 North America Everolimus Sales Breakdown by Type (2020-2025)

6.1.3 North America Everolimus Sales Breakdown by Application (2020-2025)

6.1.4 North America Everolimus Major Customer

6.1.5 North America Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Business Overview

7.1.3 Novartis Everolimus Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Novartis Everolimus Products Offered

7.1.5 Novartis Recent Development

8 Everolimus Manufacturing Cost Analysis

8.1 Everolimus Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Everolimus

8.4 Everolimus Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Everolimus Distributors List

9.3 Everolimus Customers

10 Everolimus Market Dynamics

10.1 Everolimus Industry Trends

10.2 Everolimus Market Drivers

10.3 Everolimus Market Challenges

10.4 Everolimus Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Everolimus Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Everolimus Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Everolimus Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Everolimus Sales (K Units) by Region (2020-2025)

Table 5. Global Everolimus Sales Market Share by Region (2020-2025)

Table 6. Global Everolimus Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Everolimus Revenue Share by Region (2020-2025)

Table 8. Global Everolimus Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Everolimus Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Everolimus Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Everolimus Revenue Share Forecast by Region (2026-2031)

Table 12. Global Everolimus Sales by Type (K Units) & (2020-2025)

Table 13. Global Everolimus Sales Share by Type (2020-2025)

Table 14. Global Everolimus Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Everolimus Price by Type (USD/Unit) & (2020-2025)

Table 16. Global Everolimus Sales by Type (K Units) & (2026-2031)

Table 17. Global Everolimus Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Everolimus Price by Type (USD/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Everolimus Sales by Application (K Units) & (2020-2025)

Table 21. Global Everolimus Sales Share by Application (2020-2025)

Table 22. Global Everolimus Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Everolimus Price by Application (USD/Unit) & (2020-2025)

Table 24. Global Everolimus Sales by Application (K Units) & (2026-2031)

Table 25. Global Everolimus Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Everolimus Price by Application (USD/Unit) & (2026-2031)

Table 27. New Sources of Growth in Everolimus Application

Table 28. Global Everolimus Sales by Company (K Units) & (2020-2025)

Table 29. Global Everolimus Sales Share by Company (2020-2025)

Table 30. Global Everolimus Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Everolimus Revenue Share by Company (2020-2025)

Table 32. Global Everolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Everolimus as of 2024)

Table 33. Global Market Everolimus Average Price by Company (USD/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Everolimus, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Everolimus, Product Type & Application

Table 36. Global Key Manufacturers of Everolimus, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Everolimus Sales by Company (2020-2025) & (K Units)

Table 39. North America Everolimus Sales Market Share by Company (2020-2025)

Table 40. North America Everolimus Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Everolimus Revenue Market Share by Company (2020-2025)

Table 42. North America Everolimus Sales by Type (2020-2025) & (K Units)

Table 43. North America Everolimus Sales Market Share by Type (2020-2025)

Table 44. North America Everolimus Sales by Application (2020-2025) & (K Units)

Table 45. North America Everolimus Sales Market Share by Application (2020-2025)

Table 46. Novartis Company Information

Table 47. Novartis Description and Business Overview

Table 48. Novartis Everolimus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 49. Novartis Everolimus Product

Table 50. Novartis Recent Development

Table 51. Production Base and Market Concentration Rate of Raw Material

Table 52. Key Suppliers of Raw Materials

Table 53. Everolimus Distributors List

Table 54. Everolimus Customers List

Table 55. Everolimus Market Trends

Table 56. Everolimus Market Drivers

Table 57. Everolimus Market Challenges

Table 58. Everolimus Market Restraints

Table 59. Research Programs/Design for This Report

Table 60. Key Data Information from Secondary Sources

Table 61. Key Data Information from Primary Sources

List of Figures

Figure 1. Everolimus Product Picture

Figure 2. Global Everolimus Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Everolimus Sales Market Share by Type in 2024 & 2031

Figure 4. 2.5mg Product Picture

Figure 5. 5mg Product Picture

Figure 6. 7mg Product Picture

Figure 7. 10mg Product Picture

Figure 8. Global Everolimus Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 9. Global Everolimus Sales Market Share by Application in 2024 & 2031

Figure 10. Hospital Examples

Figure 11. Drugs Store Examples

Figure 12. Other Examples

Figure 13. Global Everolimus Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Everolimus Sales Growth Rate (2020-2031) & (US$ Million)

Figure 15. Global Everolimus Sales (K Units) Growth Rate (2020-2031)

Figure 16. Global Everolimus Price Trends Growth Rate (2020-2031) & (USD/Unit)

Figure 17. Everolimus Report Years Considered

Figure 18. Global Market Everolimus Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 19. Global Everolimus Revenue Market Share by Region: 2020 VS 2024

Figure 20. North America Everolimus Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. North America Everolimus Sales (K Units) Growth Rate (2020-2031)

Figure 22. Global Everolimus Revenue Share by Type (2020-2025)

Figure 23. Global Everolimus Sales Share by Type (2026-2031)

Figure 24. Global Everolimus Revenue Share by Type (2026-2031)

Figure 25. Global Everolimus Revenue Share by Application (2020-2025)

Figure 26. Global Everolimus Revenue Growth Rate by Application in 2020 & 2024

Figure 27. Global Everolimus Sales Share by Application (2026-2031)

Figure 28. Global Everolimus Revenue Share by Application (2026-2031)

Figure 29. Global Everolimus Sales Share by Company (2024)

Figure 30. Global Everolimus Revenue Share by Company (2024)

Figure 31. Global 5 Largest Everolimus Players Market Share by Revenue in Everolimus: 2020 & 2024

Figure 32. Everolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 33. Manufacturing Cost Structure of Everolimus

Figure 34. Manufacturing Process Analysis of Everolimus

Figure 35. Everolimus Industrial Chain

Figure 36. Channels of Distribution (Direct Vs Distribution)

Figure 37. Distributors Profiles

Figure 38. Bottom-up and Top-down Approaches for This Report

Figure 39. Data Triangulation

Figure 40. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Everolimus market? zhanKai

The top companies in the global Everolimus market are Novartis.

What was the global market size of Everolimus in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Everolimus market size from 2025 to 2031? shouQi

What was the global market size of Everolimus in 2025? shouQi

Related Reports

Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Everolimus was estimated to be worth US$ 356 million in 2025 and is projected to reach US$ 206 million, growing at a CAGR of -7.6% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 116
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2026
The global Everolimus market was valued at US$ 356 million in 2025 and is anticipated to reach US$ 206 million by 2032, at a CAGR of -7.6% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 123
USD 2900.00
(Single User License)
Global Everolimus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Everolimus market is projected to grow from US$ 382 million in 2024 to US$ 221 million by 2031, at a CAGR of -7.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 110
USD 4900.00
(Single User License)
Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Everolimus was estimated to be worth US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 84
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2025
The global market for Everolimus was valued at US$ 382 million in the year 2024 and is projected to reach a revised size of US$ 221 million by 2031, growing at a CAGR of -7.6% during the forecast period.
Published Date: 2025-02-25
Pages: 81
USD 2900.00
(Single User License)
Global Everolimus Market Insights, Forecast to 2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published Date: 2024-04-25
Pages: 70
USD 4900.00
(Single User License)
Everolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published Date: 2024-01-24
Pages: 84
USD 3950.00
(Single User License)
Global Everolimus Market Research Report 2024
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published Date: 2024-01-05
Pages: 77
USD 2900.00
(Single User License)

Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Everolimus was estimated to be worth US$ 356 million in 2025 and is projected to reach US$ 206 million, growing at a CAGR of -7.6% from 2026 to 2032.
Published: 2026-07-14
Pages: 116
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2026
The global Everolimus market was valued at US$ 356 million in 2025 and is anticipated to reach US$ 206 million by 2032, at a CAGR of -7.6% from 2026 to 2032.
Published: 2026-04-27
Pages: 123
USD 2900.00 (Single User License)
Global Everolimus Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Everolimus market is projected to grow from US$ 382 million in 2024 to US$ 221 million by 2031, at a CAGR of -7.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 110
USD 4900.00 (Single User License)
Everolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Everolimus was estimated to be worth US$ 382 million in 2024 and is forecast to a readjusted size of US$ 221 million by 2031 with a CAGR of -7.6% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 84
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2025
The global market for Everolimus was valued at US$ 382 million in the year 2024 and is projected to reach a revised size of US$ 221 million by 2031, growing at a CAGR of -7.6% during the forecast period.
Published: 2025-02-25
Pages: 81
USD 2900.00 (Single User License)
Global Everolimus Market Insights, Forecast to 2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published: 2024-04-25
Pages: 70
USD 4900.00 (Single User License)
Everolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published: 2024-01-24
Pages: 84
USD 3950.00 (Single User License)
Global Everolimus Market Research Report 2024
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.
Published: 2024-01-05
Pages: 77
USD 2900.00 (Single User License)